Laura Butron

Elche, VC 03202, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis.

Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis.

Journal: ACS chemical biology

Published: March 25, 2026

An adamantane-based ligand as a novel chemical tool for thermosensory TRPM8 channel therapeutic modulation.

An adamantane-based ligand as a novel chemical tool for thermosensory TRPM8 channel therapeutic modulation.

Journal: The FEBS journal

Published: July 22, 2024

Compartmentalized primary cultures of dorsal root ganglion neurons to model peripheral pathophysiological conditions.

Compartmentalized primary cultures of dorsal root ganglion neurons to model peripheral pathophysiological conditions.

Journal: Molecular pain

Published: August 14, 2023

Design and validation of neuronal exocytosis blocking peptides as potential novel antiperspirants.

Design and validation of neuronal exocytosis blocking peptides as potential novel antiperspirants.

Journal: Experimental dermatology

Published: December 01, 2022

Phenylalanine-Derived β-Lactam TRPM8 Modulators. Configuration Effect on the Antagonist Activity.

Phenylalanine-Derived β-Lactam TRPM8 Modulators. Configuration Effect on the Antagonist Activity.

Journal: International journal of molecular sciences

Published: December 15, 2020

A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability.

A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability.

Journal: Scientific reports

Published: January 10, 2020

Is TRPA1 Burning Down TRPV1 as Druggable Target for the Treatment of Chronic Pain?

Is TRPA1 Burning Down TRPV1 as Druggable Target for the Treatment of Chronic Pain?

Journal: International journal of molecular sciences

Published: May 24, 2019

Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders.

Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders.

Journal: Journal of medicinal chemistry

Published: May 04, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026